Angiomodulatory properties of some antibiotics and Tołpa Peat Preparation. 2016

Dorota M Radomska-Leśniewska, and Ewa Skopińska-Różewska, and Jarosław Jóźwiak, and Urszula Demkow, and Barbara Joanna Bałan
Department of Histology and Embryology, Biostructure Centre, Medical University of Warsaw, Warsaw, Poland.

Deterioration of the immune system due to antibiotic therapy can be restored by immunomodulator application. In this paper we estimate the effect of ampicillin, amikacin, doxycycline, rifampicin, rifamycine and immunomodulator Tołpa Peat Preparation (TPP) on neovascular reaction induced in murine skin by human mononuclear cells (MNC) injection. MNC originating from 15 healthy volunteers were injected intradermally to Balb/c mice. Antibiotics (3, 15, or 75 mg/kg of body weight) alone or with TPP (10 mg/kg of body weight) were administrated subcutaneously to mice on three consecutive days. The number of newly formed blood vessels was measured in dissection microscope 72 hours after cell injection. RESULTS TPP stimulated angiogenic activity of MNC at the dose 5 and 10 mg/kg. Rifamycine exerted strong stimulatory action, ampicillin slightly stimulated immune response, while doxycycline and rifampicin downregulated it. Amikacin did not influence the results of angiogenesis tests. Studied antibiotics (15 mg/kg), except rifamycine, inhibit the angiostimulatory effect of the tested immunomodulator. TPP should be applied after antibiotic therapy to maintain its stimulatory effect and restore proper host immune function.

UI MeSH Term Description Entries

Related Publications

Dorota M Radomska-Leśniewska, and Ewa Skopińska-Różewska, and Jarosław Jóźwiak, and Urszula Demkow, and Barbara Joanna Bałan
January 1993, Acta poloniae pharmaceutica,
Dorota M Radomska-Leśniewska, and Ewa Skopińska-Różewska, and Jarosław Jóźwiak, and Urszula Demkow, and Barbara Joanna Bałan
January 1994, Acta poloniae pharmaceutica,
Dorota M Radomska-Leśniewska, and Ewa Skopińska-Różewska, and Jarosław Jóźwiak, and Urszula Demkow, and Barbara Joanna Bałan
November 2000, Acta poloniae pharmaceutica,
Dorota M Radomska-Leśniewska, and Ewa Skopińska-Różewska, and Jarosław Jóźwiak, and Urszula Demkow, and Barbara Joanna Bałan
January 1993, Acta poloniae pharmaceutica,
Dorota M Radomska-Leśniewska, and Ewa Skopińska-Różewska, and Jarosław Jóźwiak, and Urszula Demkow, and Barbara Joanna Bałan
January 1992, Acta poloniae pharmaceutica,
Dorota M Radomska-Leśniewska, and Ewa Skopińska-Różewska, and Jarosław Jóźwiak, and Urszula Demkow, and Barbara Joanna Bałan
January 1993, Acta poloniae pharmaceutica,
Dorota M Radomska-Leśniewska, and Ewa Skopińska-Różewska, and Jarosław Jóźwiak, and Urszula Demkow, and Barbara Joanna Bałan
January 1993, Acta poloniae pharmaceutica,
Dorota M Radomska-Leśniewska, and Ewa Skopińska-Różewska, and Jarosław Jóźwiak, and Urszula Demkow, and Barbara Joanna Bałan
January 1993, Acta poloniae pharmaceutica,
Dorota M Radomska-Leśniewska, and Ewa Skopińska-Różewska, and Jarosław Jóźwiak, and Urszula Demkow, and Barbara Joanna Bałan
January 1993, Acta poloniae pharmaceutica,
Dorota M Radomska-Leśniewska, and Ewa Skopińska-Różewska, and Jarosław Jóźwiak, and Urszula Demkow, and Barbara Joanna Bałan
January 1993, Acta poloniae pharmaceutica,
Copied contents to your clipboard!